Aarti Industries Ltd (AARTIIND)
Stock Analysis Report
Stock Journey
Key Positives and Key Risks
Pros
- Revenue growth of 13.2% quarter-over-quarter demonstrates strong top-line momentum.
- Gross margin of approximately 40% indicates efficient production and pricing power.
- Market capitalization of ₹169.28 billion reflects a substantial and stable market presence.
Cons
- Current ratio of 0.83 suggests potential short-term liquidity constraints.
- Negative levered free cash flow of approximately ₹-6.46 billion indicates ongoing capital expenditure or debt servicing pressures.
- Return on equity at 7.25% is relatively modest compared to industry peers, highlighting room for improved profitability.
Disclosure: This information is for general awareness and does not constitute investment advice
Report Summary
Aarti Industries Ltd. is a prominent Indian manufacturer specializing in specialty chemicals and pharmaceuticals, operating primarily on the NSE exchange within the Basic Materials sector. The company produces a diverse range of high-performance chemicals serving industries such as agrochemicals, polymers, pigments, and pharmaceuticals. Headquartered in Mumbai, Aarti Industries leverages advanced technology and extensive R&D capabilities to maintain a strong market position domestically and internationally. Its business segments include chemical intermediates critical to various industrial applications, reinforcing its role in the global chemical supply chain.
Financially, Aarti Industries reported trailing twelve months (TTM) revenue of approximately ₹82.86 billion with a gross margin of 40.09%, an operating margin of 9.84%, and a net profit margin of 5.06%. The return on equity (ROE) stands at 7.25%, and return on assets (ROA) is 3.47%, indicating moderate profitability and efficient asset utilization. The company’s operating cash flow for the TTM is ₹7.81 billion, although levered free cash flow is negative at around ₹-6.46 billion, reflecting ongoing capital expenditures or debt servicing. These metrics suggest a stable but capital-intensive operation with room for margin improvement.
Valuation metrics show a trailing price-to-earnings (P/E) ratio of 40.33 and a forward P/E of 22.87, with a price-to-book (P/B) ratio of 2.83 and an enterprise value to EBITDA (EV/EBITDA) multiple of 18.43. The market capitalization is approximately ₹169.28 billion. The stock trades at ₹482.70, within a 52-week range of ₹523.10 (high) to ₹338.05 (low), currently closer to the upper end of this range. The PEG ratio is notably low at 0.20, suggesting the market may be pricing in significant growth potential relative to earnings.
Key strengths include robust revenue growth of 13.2% quarter-over-quarter, a strong gross margin above 40%, and a solid market position in specialty chemicals. The company maintains a manageable debt-to-equity ratio of 0.83, although the current ratio is below 1.0 at 0.83, indicating tighter short-term liquidity. Risks include exposure to raw material price volatility, competitive pressures within the specialty chemicals industry, and macroeconomic uncertainties impacting global supply chains. Recent strategic actions include margin expansion efforts and securing key contracts, which have contributed to improved operational efficiency.
Technically, the stock is trading above its 50-day (₹444.35) and 200-day (₹401.72) moving averages, indicating a positive medium- to long-term trend. Momentum indicators such as RSI and MACD suggest moderate strength without overbought conditions. Recent news highlights strong quarterly financial results and operational resilience amid global challenges. Overall, the data suggests a balanced environment where accumulation or monitoring for further developments may be appropriate, reflecting neither extreme bullish nor bearish conditions.
Company and Industry Overview
Company Basics
Price Performance
Company Size
Aarti Industries Ltd.'s shareholding structure comprises approximately 42.49% held by insiders including executives and board members, 23.16% by institutional investors such as mutual funds and pension funds, and the remaining 34.35% by public shareholders including retail investors. Over the past 12 to 24 months, institutional ownership has shown moderate accumulation, reflecting growing confidence from major funds. The presence of significant promoter ownership suggests strong governance alignment with long-term strategic goals. This ownership pattern indicates a balanced market sentiment with institutional support while maintaining broad public participation, which may influence future corporate decisions and strategic initiatives.
Sector and Industry Analysis
The chemicals sector, particularly speciality chemicals, is a significant contributor to the global industrial landscape, with a market size expanding steadily due to diverse applications across pharmaceuticals, agrochemicals, and consumer goods. Growth is propelled by rising demand for high-value, customised chemical products, with leading players including global firms and strong Indian companies like Aarti Industries, which ranks among the top five globally for 75% of its product portfolio. The sector benefits from robust export opportunities, especially in mature markets such as the US, Europe, and Japan, driving revenue growth and capacity expansions.
Industry trends reveal a shift towards value-added speciality chemicals and custom synthesis, which command higher margins and foster long-term customer relationships. Companies like Aarti Industries are investing in capex to enhance their speciality chemical revenue streams and improve margin profiles through a higher share of value-added products. Barriers to entry remain high due to the need for advanced technology, regulatory compliance, and established global customer bases, creating competitive advantages for incumbents with strong R&D and diversified product offerings.
The regulatory landscape for the chemicals sector is increasingly stringent, focusing on environmental compliance, safety standards, and export controls, which impact operational costs and capital expenditure decisions. Indian speciality chemical firms must navigate both domestic regulations and international standards to maintain market access, particularly in developed economies with rigorous quality and environmental norms. Ongoing regulatory developments are expected to drive further investments in sustainable practices and innovation, shaping the sector’s growth trajectory and competitive positioning.
Note: Analysis synthesized from industry research, market reports, and regulatory filings. Information is subject to change based on market conditions.
Financial Ratios Dashboard
Illustrative Scenario Analysis
DCF Assumptions:
Method: Two-Stage EPS-Priority Model
Financials
Peer Analysis
| Company Name | Market Cap | P/E Ratio | P/B Ratio | EV/EBITDA | Price to CFO |
|---|---|---|---|---|---|
| Aarti Industries Ltd. | ₹169.28B | 40.33 | 2.83 | 18.43 | 21.67 |
| Asian Paints Ltd. | ₹2.50T | 65.17 | 12.77 | 42.70 | 52.73 |
| Vinati Organics Ltd. | ₹137.23B | 30.89 | 4.67 | 20.37 | 33.03 |
| Atul Ltd. | ₹209.04B | 30.87 | 3.36 | 18.47 | 20.44 |
| Balaji Amines Ltd. | ₹55.28B | 38.36 | 2.94 | 17.57 | 30.04 |
| Kansai Nerolac Paints Ltd. | ₹179.58B | 30.50 | 2.77 | 16.03 | 20.08 |
Comparison Analysis: Aarti Industries Ltd. trades at a higher P/E ratio of 40.33 compared to most of its peers, indicating a premium valuation relative to earnings. Its P/B ratio of 2.83 is moderate, lower than Asian Paints but comparable to Kansai Nerolac and Balaji Amines. The EV/EBITDA multiple of 18.43 is in line with Atul Ltd. and slightly above Kansai Nerolac, reflecting similar operational profitability expectations. Return on equity at 7.25% is lower than most peers, suggesting room for improvement in shareholder returns. Price to CFO at 21.67 is relatively conservative compared to Asian Paints and Vinati Organics, indicating a more reasonable valuation on cash flow basis.
Financial Metrics Comparison with Peers
Financial Statements
Comprehensive financial data including income, balance sheet, and cash flow metrics
Income Statement
| fiscal_date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Sales | 71.31B | 61.93B | 64.92B | 51.91B | 43.05B |
| Cost Of Goods | 53.75B | 46.55B | 46.95B | 36.02B | 28.63B |
| Gross Profit | 17.56B | 15.38B | 17.98B | 15.89B | 14.42B |
| Operating Expense Selling General And Administrative | 4.35B | 3.09B | 4.31B | 3.87B | 2.62B |
| Operating Expense Other Operating Expenses | 11.93B | 11.12B | 13.03B | 19.40B | 600.00K |
| Operating Income | 6.00B | 6.23B | 7.96B | 14.86B | 7.66B |
| Non Operating Interest Income | 149.50M | 70.90M | 0.00 | N/A | N/A |
| Non Operating Interest Expense | 2.36B | 1.83B | 1.06B | 686.30M | 767.10M |
| Pretax Income | 3.07B | 3.95B | 6.11B | 13.72B | 6.65B |
| Income Tax | -236.30M | -210.50M | 658.70M | 1.86B | 1.29B |
| Net Income | 3.31B | 4.16B | 5.45B | 11.86B | 5.35B |
| Eps Basic | 9.13 | 11.49 | 15.04 | 32.71 | 15.02 |
| Eps Diluted | 9.12 | 11.49 | 15.04 | 32.71 | 15.02 |
| Basic Shares Outstanding | 362.53M | 362.50M | 362.50M | 362.50M | 348.47M |
| Diluted Shares Outstanding | 362.53M | 362.50M | 362.50M | 362.50M | 348.47M |
| Ebit | 5.44B | 5.79B | 7.17B | 14.41B | 7.41B |
| Ebitda | 9.86B | 9.62B | 10.28B | 16.87B | 9.73B |
| Net Income Continuous Operations | 3.05B | 3.95B | 6.11B | 13.72B | 6.65B |
| Minority Interests | 0.00 | 0.00 | 0.00 | -2.30M | -117.50M |
| Preferred Stock Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: Financial statements and regulatory filings
Balance Sheet
| fiscal_date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.99B | 417.80M | 1.67B | 936.30M | 4.10B |
| Accounts Receivable | 7.86B | 8.26B | 9.40B | 10.92B | 7.94B |
| Total Assets | 111.14B | 96.16B | 85.81B | 78.51B | 76.42B |
| Total Liabilities | 55.08B | 43.25B | 36.60B | 33.33B | 41.27B |
| Long Term Debt | 19.15B | 15.73B | 6.60B | 9.45B | 12.81B |
| Shareholders Equity | 56.05B | 52.90B | 49.21B | 45.17B | 35.15B |
Source: Financial statements and regulatory filings
Cash Flow Statement
| fiscal_date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Operating Activities Net Income | 3.05B | 3.95B | 6.11B | 13.72B | 6.65B |
| Operating Activities Other Non Cash Items | 2.37B | 1.95B | 1.13B | 766.00M | 810.60M |
| Operating Activities Accounts Receivable | 437.70M | 685.50M | 4.22B | -4.98B | -250.10M |
| Operating Activities Other Assets Liabilities | -2.95B | -1.29B | -969.20M | -4.20B | -1.11B |
| Operating Activities Operating Cash Flow | 2.91B | 5.30B | 10.50B | 5.31B | 6.10B |
| Investing Activities Capital Expenditures | -13.79B | -13.04B | -13.26B | -11.65B | -13.14B |
| Investing Activities Net Acquisitions | -234.50M | 0.00 | 0.00 | 0.00 | 0.00 |
| Investing Activities Other Investing Activity | 600.00K | 400.00K | 600.00K | 500.00K | 500.00K |
| Investing Activities Investing Cash Flow | -14.02B | -13.04B | -13.30B | -11.69B | -13.22B |
| Financing Activities Long Term Debt Issuance | 7.03B | 12.92B | 15.27B | N/A | 10.08B |
| Financing Activities Long Term Debt Payments | -4.55B | -9.82B | -12.21B | N/A | -2.62B |
| Financing Activities Common Stock Issuance | 100.00K | N/A | 0.00 | 11.87B | 0.00 |
| Financing Activities Common Dividends | -362.50M | -543.80M | -906.30M | -1.27B | -450.90M |
| Financing Activities Other Financing Charges | -10.00M | -10.00M | N/A | N/A | N/A |
| Financing Activities Financing Cash Flow | 2.11B | 2.54B | 2.15B | 10.60B | 7.01B |
| End Cash Position | 1.99B | 1.30B | 2.01B | 1.74B | 4.12B |
| Free Cash Flow | -1.44B | -1.24B | -75.60M | -6.47B | -4.42B |
| Investing Activities Purchase Of Investments | N/A | N/A | -35.40M | -50.00M | -78.20M |
| Investing Activities Sale Of Investments | N/A | N/A | 0.00 | 5.20M | 0.00 |
| Financing Activities Common Stock Repurchase | N/A | N/A | N/A | N/A | N/A |
Source: Financial statements and regulatory filings
Technical Analysis
Key Insights
- The current trend shows a bullish momentum with the stock price trading above both the 50-day (₹444.35) and 200-day (₹401.72) moving averages, indicating medium- to long-term strength.
- Key support levels are identified near ₹440 and ₹400, while resistance is observed around the 52-week high of ₹523.
- The stock is positioned above the 10-day moving average, reinforcing short-term upward momentum.
- Momentum indicators show RSI in the mid-60s range, suggesting moderate strength without overbought conditions; MACD is positive with a bullish crossover recently confirmed.
- Multi-timeframe analysis reveals consistent upward trends on daily, weekly, and monthly charts, supporting sustained positive price action.
- Potential scenarios include continuation of the uptrend if support levels hold, while a break below ₹440 could signal consolidation or correction.
Trending News
1. Headline: Stay Informed with MarketsMojo News: Stock Market Insights, Portfolio Tracking, Alerts, and Expert Analyses
Summary: Latest news on Stocks in Action, Trending Stocks, Stock Analysis, Result Analysis, Corporate News, Stock Market News, IPOs, Mutual Funds, Global Markets, and Investment Ideas at MarketsMojo. Enhance your financial decisions with insightful stock market analysis, seamless portfolio tracking, ...
Sentiment: neutral
2. Headline: Aarti Drugs Limited Just Recorded A 6.8% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St News
Summary: Aarti Drugs Limited ( NSE:AARTIDRUGS ) last week reported its latest full-year results, which makes it a good time for...
Sentiment: positive
3. Headline: Aarti Drugs Ltd (BOM:524348) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges
Summary: Aarti Drugs Ltd (BOM:524348) reports robust revenue and EBITDA growth, while navigating input cost pressures and geopolitical challenges.
Sentiment: positive
Summary: Home / Markets / Capital Market News / Aarti Drugs consolidated net profit declines 12.20% in the March 2026 quarter
Sentiment: negative
Summary: Last week saw the newest annual earnings release from Aarti Industries Limited ( NSE:AARTIIND ), an important milestone...
Sentiment: positive
Recent Updates
News Summary
As of the latest reports in May 2026, Aarti Industries Ltd. delivered strong financial performance for fiscal year 2026 with revenue reaching ₹9,018 crore, representing a 12% year-over-year increase. The company showed notable growth in EBITDA and PAT, reflecting enhanced operational efficiency despite challenging market conditions. In Q4 2026, the firm sustained 12% revenue growth year-on-year and secured key strategic contracts, underscoring resilience amid global headwinds. These developments demonstrate effective management of cost pressures and successful execution of growth initiatives within the specialty chemicals sector.
News Sentiment
The overall sentiment from recent updates is predominantly positive, driven by solid revenue growth, margin expansion, and strategic contract wins. Positive narratives around operational efficiency and resilience counterbalance isolated negative news such as profit declines reported by related entities in the sector. The company’s ability to navigate macroeconomic and geopolitical challenges while maintaining growth contributes to a constructive outlook. However, cautiousness remains warranted given the broader industry headwinds and input cost volatility.
Source List
- https://www.investywise.com/aarti-industries-q4-fy26-performance-update/
- https://www.investywise.com/aarti-industries-q4-and-annual-fy26-results/
Analytical Overview
Analysis Summary
Aarti Industries' valuation metrics show a trailing P/E of 40.33 and a forward P/E of 22.87, which are higher than some industry peers but supported by a low PEG ratio of 0.20, indicating expected earnings growth. Revenue growth stands at 13.2% quarter-over-quarter, with improving cash flow trends, although free cash flow remains negative, suggesting ongoing capital investments. The company maintains a debt-to-equity ratio of 0.83, reflecting moderate leverage, but the current ratio below 1.0 signals potential short-term liquidity constraints. Sector-specific challenges include raw material price volatility and global supply chain disruptions, while opportunities arise from pricing discipline and strategic contract wins. Considering India-specific factors, regulatory compliance and growing domestic demand in specialty chemicals support the company’s growth trajectory.
Overall Business and Market Assessment
Supporting Factors: robust revenue growth of 13.2%, strong gross margins above 40%, and strategic contract acquisitions enhancing future prospects
Risk Factors: input cost inflation, short-term liquidity indicated by a current ratio of 0.83, and competitive pressures within the specialty chemicals sector
SWOT Analysis
Strengths
- Strong revenue growth of 13.2% quarter-over-quarter.
- Robust gross margin of approximately 40%.
- Diverse product portfolio serving multiple industrial sectors.
- Solid market position in the Indian specialty chemicals industry.
Weaknesses
- Current ratio below 1.0 indicating tight short-term liquidity.
- Negative levered free cash flow suggesting capital expenditure pressures.
- Return on equity at 7.25% is modest compared to peers.
- Moderate operating margin of 9.84% limits profitability expansion.
Opportunities
- Pricing discipline and volume recovery to support margin expansion.
- Strategic contracts enhancing revenue visibility and growth.
- Growing domestic and international demand for specialty chemicals.
- Potential for technological innovation through R&D investments.
Threats
- Volatility in raw material prices impacting input costs.
- Geopolitical tensions affecting global supply chains.
- Competitive pressures from domestic and international players.
- Macroeconomic uncertainties influencing demand and pricing.
Company Description
Aarti Industries Ltd. is a leading Indian chemical manufacturer specializing in the production of specialty chemicals and pharmaceuticals. The company's primary focus lies in creating a diverse portfolio of high-performance chemicals that serve various industries including agrochemicals, polymers, pigments, and pharmaceuticals. Notable for its robust capabilities in chemistry, Aarti Industries Ltd. provides crucial intermediates that support global industrial applications ranging from manufacture of dyes and pigments, additives, to those required in healthcare and agrichemicals. The company is strategically significant in the chemical supply chain, enabling sectors to enhance product performance and efficiency. Headquartered in Mumbai, India, Aarti Industries Ltd. leverages cutting-edge technology and infrastructure, ensuring compliance with rigorous safety and environmental standards. Its expansive production and R&D facilities allow for continuous innovation and adaptability, reinforcing its market position both domestically and internationally. As such, Aarti Industries Ltd. plays a pivotal role in bridging raw chemical production and end-user product transformations across multiple industry sectors.

